- Galena Biopharma (GALE -16.9%) plunges after Bronte Capital's John Hempton ridicules the company for marketing its fentanyl-based painkiller Abstral with free samples - "a new low in the pharmaceutical industry."
- GALE's giveaway is "evil," Hempton writes; it's "doing hippie alternative lifestyle drug marketing for drugs that are especially effective in turning you into a zombie."
- Adam Feuerstein reminds investors that when examining Q4 and 2013 results, "market share gains derived from free samples don't mean much."
- Matt Gravitt recently posted his own negative critique on SA, highlighting "numerous red flags" which suggest a "significant overvaluation."
Galena Biopharma -17% after report rips painkiller drug sample giveaway
Recommended For You
About SLS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SLS | - | - |
SELLAS Life Sciences Group, Inc. |